2BB score and signals
Quince Therapeutics, Inc.’s current 2BB score is 2 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 1 | Very Weak |
| Quality | 60 | Strong |
| Risk | 74 | High |
2BBBullish & Bearish
Quince Therapeutics, Inc. (QNCX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 2 out of 100.
Quince Therapeutics, Inc.’s current 2BB score is 2 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 1 | Very Weak |
| Quality | 60 | Strong |
| Risk | 74 | High |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-04-08 | — | -3.7985 | — | $0.00 |
| 2026-11-10 | — | -3.6661 | — | $0.00 |
| 2026-08-10 | — | -18.2376 | — | $0.00 |
| 2026-05-11 | — | -2.6112 | — | $0.00 |